RecruitingNCT06031805

PRostate Olaparib Real World Evidence Study

A French Observational Longitudinal Multicenter Study of Adult Patients Treated in the Real-life Setting With Olaparib for the Treatment of Metastatic Castration Resistant Prostate Cancer

Sponsor

AstraZeneca

Enrollment

300 participants

Start Date

Oct 11, 2023

Study Type

OBSERVATIONAL

Conditions

Metastatic Castration-resistant Prostate Cancer

Summary

This French non-interventional longitudinal multicenter cohort study is conducted to study the added value of olaparib in the treatment of patients with mCRPC in the real world setting in terms of treatment sequencing, effectiveness, safety and BRCA testing patterns and thus inform future clinical practice.

Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is an observational study (no experimental treatment) collecting real-world data on how olaparib — an approved drug — is used in men with metastatic castration-resistant prostate cancer that has spread and no longer responds to hormone therapy. **You may be eligible if...** - You are an adult male (18 or older) - You have metastatic castration-resistant prostate cancer - Your doctor has decided to treat you with olaparib, or you have started it within the past 2 months - You are willing to have your medical data collected **You may NOT be eligible if...** - You object to your data being collected for research - You are currently enrolled in a clinical trial testing an investigational prostate cancer drug Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(65)

Research Site

Amiens, France

Research Site

Angers, France

Research Site

Antony, France

Research Site

Argenteuil, France

Research Site

Avignon, France

Research Site

Avignon, France

Research Site

Besançon, France

Research Site

Bordeaux, France

Research Site

Bordeaux, France

Research Site

Challes-les-Eaux, France

Research Site

Chambray-lès-Tours, France

Research Site

Chambray-lès-Tours, France

Research Site

Champigny-sur-Marne, France

Research Site

Clermont-Ferrand, France

Research Site

Clermont-Ferrand, France

Research Site

Compiègne, France

Research Site

Créteil, France

Research Site

Créteil, France

Research Site

Epagny METZ Tessy, France

Research Site

Epagny METZ Tessy, France

Research Site

Ermont, France

Research Site

FORT de France, France

Research Site

Fréjus, France

Research Site

Fréjus, France

Research Site

Grenoble, France

Research Site

Le Chesnay, France

Research Site

Le Coudray, France

Research Site

Le Coudray, France

Research Site

Le Mans, France

Research Site

Levallois-Perret, France

Research Site

Lyon, France

Research Site

Lyon, France

Research Site

Mantes-la-Jolie, France

Research Site

Mantes-la-Jolie, France

Research Site

Marseille, France

Research Site

Morlaix, France

Research Site

Nancy, France

Research Site

Nancy, France

Research Site

Nantes, France

Research Site

Nice, France

Research Site

ORL ANS, France

Research Site

Paris, France

Research Site

Paris, France

Research Site

Pointe à Pitre, France

Research Site

Poitiers, France

Research Site

Pontoise, France

Research Site

Quint-Fonsegrives, France

Research Site

Rouen, France

Research Site

Rouen, France

Research Site

Saint Denis- LA Reunion, France

Research Site

Saint-Doulchard, France

Research Site

Saint-Etienne, France

Research Site

Saint-Etienne, France

Research Site

Saint-Grégoire, France

Research Site

Saint-Grégoire, France

Research Site

Saint-Mandé, France

Research Site

Saint-Nazaire, France

Research Site

Saint-Nazaire, France

Research Site

Strasbourg, France

Research Site

Suresnes, France

Research Site

Tours, France

Research Site

Tours, France

Research Site

Vannes, France

Research Site

Vantoux, France

Research Site

Vantoux, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06031805

Related Trials

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

NCT07213674125 locations

Intestinal Akkermansia Muciniphila in Prostate Cancer

NCT062425091 location

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

NCT075458111 location

Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes

NCT0643922514 locations

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

NCT057663711 location